(2R)-2-(diethylamino)-1-[(2R,3R,5S)-5-[6-[6-[2-[(2S,4R,5R)-1-[(2R)-2-(diethylamino)-2-phenylacetyl]-4,5-dimethylpyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-benzimidazol-2-yl]-2,3-dimethylpyrrolidin-1-yl]-2-phenylethanone
C60H68N8O2 — CID 131967626
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-(diethylamino)-1-[(2R,3R,5S)-5-[6-[6-[2-[(2S,4R,5R)-1-[(2R)-2-(diethylamino)-2-phenylacetyl]-4,5-dimethylpyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-benzimidazol-2-yl]-2,3-dimethylpyrrolidin-1-yl]-2-phenylethanone
(2R)-2-(diethylamino)-1-[(2R,3R,5S)-5-[6-[6-[2-[(2S,4R,5R)-1-[(2R)-2-(diethylamino)-2-phenylacetyl]-4,5-dimethylpyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-benzimidazol-2-yl]-2,3-dimethylpyrrolidin-1-yl]-2-phenylethanone (PubChem CID 131967626) has the molecular formula C60H68N8O2 and a molecular weight of 933.26 g/mol. Its IUPAC name is (2R)-2-(diethylamino)-1-[(2R,3R,5S)-5-[6-[6-[2-[(2S,4R,5R)-1-[(2R)-2-(diethylamino)-2-phenylacetyl]-4,5-dimethylpyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-benzimidazol-2-yl]-2,3-dimethylpyrrolidin-1-yl]-2-phenylethanone.
Molecular Properties
| Compound Name | (2R)-2-(diethylamino)-1-[(2R,3R,5S)-5-[6-[6-[2-[(2S,4R,5R)-1-[(2R)-2-(diethylamino)-2-phenylacetyl]-4,5-dimethylpyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-benzimidazol-2-yl]-2,3-dimethylpyrrolidin-1-yl]-2-phenylethanone |
|---|---|
| PubChem CID | 131967626 |
| Molecular Formula | C60H68N8O2 |
| Molecular Weight | 933.26 g/mol |
| Exact Mass | 932.55 |
| IUPAC Name | (2R)-2-(diethylamino)-1-[(2R,3R,5S)-5-[6-[6-[2-[(2S,4R,5R)-1-[(2R)-2-(diethylamino)-2-phenylacetyl]-4,5-dimethylpyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-benzimidazol-2-yl]-2,3-dimethylpyrrolidin-1-yl]-2-phenylethanone |
| SMILES | CCN(CC)[C@@H](C(=O)N1[C@H](C)[C@H](C)C[C@H]1c1nc2ccc(-c3ccc4cc(-c5ccc6nc([C@@H]7C[C@@H](C)[C@@H](C)N7C(=O)[C@@H](c7ccccc7)N(CC)CC)[nH]c6c5)ccc4c3)cc2[nH]1)c1ccccc1 |
| InChI | InChI=1S/C60H68N8O2/c1-9-65(10-2)55(41-19-15-13-16-20-41)59(69)67-39(7)37(5)31-53(67)57-61-49-29-27-47(35-51(49)63-57)45-25-23-44-34-46(26-24-43(44)33-45)48-28-30-50-52(36-48)64-58(62-50)54-32-38(6)40(8)68(54)60(70)56(66(11-3)12-4)42-21-17-14-18-22-42/h13-30,33-40,53-56H,9-12,31-32H2,1-8H3,(H,61,63)(H,62,64)/t37-,38-,39-,40-,53+,54+,55-,56-/m1/s1 |
| InChIKey | YWGKOIUZKIKPNB-MLIQGRDDSA-N |
| XLogP | 12.69 |
| TPSA | 104.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 70 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 933.26 |
| LogP ≤ 5 | 12.69 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 131967626 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.